In contrast, it was shown that several human cancers harbor inactivating mutations or deletions in several atg genes, including atg67/beclin-1,46 its partner UVRAG,47 as well as atg2B, atg5 and atg9B,48 what defines them as tumor-suppressor genes. This evidence concerns the gene ATG5 and neoplasm.